BHRT vs traditional HRT: which should I ask for and where?

Short answer

• Start by asking for an evidence‑based, individualized plan from a clinician who treats menopause (OB‑GYN, family physician with menopause experience, or an endocrinologist/menopause specialist).
• If you want “bioidentical” hormones, ask first for FDA‑approved bioidentical products (transdermal 17β‑estradiol + micronized progesterone) rather than custom‑compounded BHRT. These have known dosing, quality control and safety data.
• If you’re still considering compounded BHRT, only proceed after discussing limits/risks with a menopause specialist and using an accredited compounding pharmacy.

Key differences (brief)

• Traditional HRT usually refers to FDA‑approved products such as conjugated equine estrogens (e.g., Premarin) or synthetic progestins (e.g., medroxyprogesterone/Provera). Efficacy proven, but some formulations had specific risk signals in large trials.
• “Bioidentical” often means hormones chemically identical to human hormones. Many FDA‑approved estradiol products (Estrace, Climara, Vivelle‑Dot, Estrogel/Divigel) and micronized progesterone (Prometrium) are bioidentical and regulated. “Compounded BHRT” are custom mixes from compounding pharmacies that are NOT FDA‑tested for safety/dose consistency.

Which to ask for (recommended)

• Prefer FDA‑approved bioidentical estradiol delivered transdermally (patch or gel) plus micronized progesterone when a progestogen is needed:
  • Examples: Climara or Vivelle‑Dot (estradiol patches), Estrogel/Divigel (gels), Estrace (oral estradiol); Prometrium (micronized progesterone).
  • Why: transdermal estradiol may have lower risk of blood clots than oral estrogen; Prometrium is FDA‑approved micronized progesterone (closer to natural progesterone) with better safety data than some synthetic progestins in some studies.
• Avoid choosing compounded BHRT as a first choice unless there’s a clear reason (e.g., allergy to excipients, need for a dose/form not available) and you understand the tradeoffs.

Where to go / who to see

• Start with: your OB‑GYN, primary care doctor, or an endocrinologist who has experience with menopause. Ask whether they are a North American Menopause Society (NAMS) Certified Menopause Practitioner. NAMS has a provider locator (menopause.org).
• For a second opinion or complicated cases: large academic centers/menopause clinics such as Mayo Clinic or Cleveland Clinic (or your regional academic medical center) have menopause programs. They follow current evidence and offer multidisciplinary care.
• Telehealth options: clinics that offer menopause‑focused care (search for “menopause clinic telemedicine” or use services like Maven Clinic or other women’s health telemedicine platforms) — confirm the clinician’s menopause credentials.
• If considering compounded BHRT: use a USP‑compliant, accredited compounding pharmacy and ask the clinician to document why compounding is needed. (Avoid relying on saliva hormone tests for dosing—these are not recommended for routine treatment decisions.)

What to ask your clinician (practical)

• “Based on my symptoms and risk factors, would you recommend transdermal estradiol plus micronized progesterone, oral estrogen, or another option?”
• “Can we use FDA‑approved estradiol (patch/gel) and Prometrium before considering compounded formulas?”
• Baseline checks: mammogram per age guidelines, blood pressure, lipid/glucose screening, and discussion of clot/stroke/breast cancer risks. Plan for follow‑up monitoring and symptom checks.

If you want, tell me:

• your main symptoms, age, menstrual/medical history, and any risk factors (VTE, stroke, breast cancer, smoking). I can give more specific phrasing to use with a clinician and tailor a recommendation.